News

Background and objectives Brain metastases from ovarian cancer (BMFOC) are rare but associated with poor prognosis. This ...
Gamma Knife is the leading stereotactic radiosurgery (SRS) platform, offering unparalleled accuracy in both the localization and radiation dose delivered to targeted brain tissue. In China, more ...
Elekta, a Swedish company that provides radiation therapy equipments, has received European CE marking for its new Leksell Gamma Knife Icon radiosurgery system. The licence is mandatory for ...
Dr. Alison Cameron, Clinical Lead for the Bristol Gamma Knife, says: “Icon will allow Bristol to offer an intracranial stereotactic service without any compromises. The system has the ...
Elekta landed FDA regulatory clearance for its Leksell Gamma Knife Icon, its latest radiosurgery system for treating targets just about anywhere in the brain. The system features stereotactic ...
The first patient to have Leksell Gamma Knife® stereotactic radiosurgery in a clinical setting had his procedure to treat a pituitary adenoma at Sophiahemmet Hospital in Stockholm on January 27 ...
The global veterinary stereotactic radiosurgery system market size is anticipated to reach USD 5.71 billion by 2030 and is expected to expand a CAGR of 10.4% from 2024 to 2030.
Even with Gamma Knife radiosurgery to treat the tumor arising from this very delicate neural structure, hearing was preserved similarly in both groups.
The role of radiosurgery in the treatment of grade 2 meningioma remains unclear. This study aimed to evaluate the long-term outcomes of gamma knife radiosurgery (GKRS) in patients with grade 2 ...
Gamma Knife surgery is only one type of stereotactic radiosurgery. This is a powerful and precise radiation therapy that most often involves just one treatment of a high dose of radiation in a ...
Gamma Knife is the leading stereotactic radiosurgery (SRS) platform, offering unparalleled accuracy in both the localization and radiation dose delivered to targeted brain tissue. In China, more ...